157 related articles for article (PubMed ID: 3925217)
1. [Anti-angina effectiveness of isosorbide dinitrate in an acute trial and following continuous 4-week therapy with 40 mg 6 times a day].
Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
Klin Wochenschr; 1985 May; 63(10):460-7. PubMed ID: 3925217
[TBL] [Abstract][Full Text] [Related]
2. Sustained antianginal efficacy of oral high-dose isosorbide dinitrate in patients with coronary heart disease.
Schneider W; Wietschoreck A; Bussmann WD; Kaltenbach M
Z Kardiol; 1983; 72 Suppl 3():259-67. PubMed ID: 6666231
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antianginal efficacy of isosorbide dinitrate (ISDN) 40 mg and verapamil 120 mg three times daily in the acute trial and following two-week treatment.
Schneider W; Maul FD; Bussmann WD; Lang E; Hör G; Kaltenbach M
Eur Heart J; 1988 Feb; 9(2):149-58. PubMed ID: 3280317
[TBL] [Abstract][Full Text] [Related]
4. [Development of tolerance with regard to the anti-ischemic effect of isosorbide dinitrate in regular multiple daily administration].
Reiniger G; Blasini R; Brügmann U; Rudolph W
Herz; 1984 Jun; 9(3):146-52. PubMed ID: 6430768
[TBL] [Abstract][Full Text] [Related]
5. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
[TBL] [Abstract][Full Text] [Related]
6. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
[TBL] [Abstract][Full Text] [Related]
7. Dose-response relation of antianginal activity of isosorbide dinitrate.
Schneider WU; Bussmann WD; Stahl B; Kaltenbach M
Am J Cardiol; 1984 Mar; 53(6):700-5. PubMed ID: 6702616
[TBL] [Abstract][Full Text] [Related]
8. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris.
Wagner F; Gohlke-Bärwolf C; Trenk D; Jähnchen E; Roskamm H
Eur Heart J; 1991 Sep; 12(9):994-9. PubMed ID: 1936012
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of the development of tolerance to isosorbide dinitrate in interval therapy].
Blasini R; Reiniger G; Brügmann U; Rudolph W
Herz; 1984 Jun; 9(3):166-70. PubMed ID: 6378743
[TBL] [Abstract][Full Text] [Related]
10. Antianginal efficacy of long-term nitrate therapy.
Kenedi P; Giebeler B
Z Kardiol; 1983; 72 Suppl 3():233-8. PubMed ID: 6666227
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Kośmicki M; Sadowski Z
Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
[TBL] [Abstract][Full Text] [Related]
12. Increased exercise tolerance and reduced duration of ischemia after isosorbide dinitrate oral spray in angina pectoris.
Marmor A; Plich M; Blondheim D; Sharir T; Alpert JS
Am J Cardiol; 1988 Mar; 61(9):4E-6E. PubMed ID: 3348139
[TBL] [Abstract][Full Text] [Related]
13. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
[TBL] [Abstract][Full Text] [Related]
14. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
Blasini R; Brügmann U; Reiniger G; Rudolph W
Herz; 1985 Jun; 10(3):163-71. PubMed ID: 3926613
[TBL] [Abstract][Full Text] [Related]
15. The development and reversal of tolerance to antianginal effect of isosorbide dinitrate in patients with effort angina.
Toyosaki N; Katsuki T; Fujii M; Kawada Y; Komaba A; Watabiki H; Hasegawa H; Suzuki S; Natsume T; Yaginuma T
Jpn Circ J; 1989 May; 53(5):395-405. PubMed ID: 2769927
[TBL] [Abstract][Full Text] [Related]
16. [Dose-effect relationship of isosorbide dinitrate in the treatment of angina pectoris (author's transl)].
Schneider W; Stahl B; Kaltenbach M; Bussmann WD
Dtsch Med Wochenschr; 1982 May; 107(20):771-6. PubMed ID: 7075499
[TBL] [Abstract][Full Text] [Related]
17. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
Vogler AC; Silber S; Spiegelsberger F; Theisen K
Z Kardiol; 1989 Jul; 78(7):421-6. PubMed ID: 2672652
[TBL] [Abstract][Full Text] [Related]
18. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
Neuhaus R; Johnen R; Vydra L; Solbach C
Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
[TBL] [Abstract][Full Text] [Related]
19. An open, long-term, multi-centre study of the anti-anginal efficacy and safety of isosorbide 5-mononitrate at low doses in patients with coronary heart disease.
Uberbacher HJ; Steinorth G; Glocke M; Abshagen U
Pharmatherapeutica; 1983; 3(5):331-41. PubMed ID: 6342004
[TBL] [Abstract][Full Text] [Related]
20. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
Döring G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
